Global Recombinant Expression Systems Market Research Report - Industry Analysis and Forecast To 2019
- ID:PD000418
- October 2018
- Value Market Research
An expression system is a system specifically designed for the production of a gene product of choice. This is normally a protein although may also be RNA, such as tRNA or a ribozyme. An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided. Expression systems are classified on the basis of functionality, solubility, yield, level of target gene expression, and post translational processing.
The recombinant expression systems market is expected to grow owing to increased research in pharmaceutical sector and growth in biologics market. The overall growth in proteomics market is also a major factor driving this market. Decreased R&D expenditure and high market consolidation will hamper the growth of this market. Developing countries are expected to be high opportunity regions for global recombinant expression systems market.
This report segments the global recombinant expression market based on expression systems, products, and end users. This market is segmented on the basis of expression systems into insect cell expression systems, mammalian cell expression systems, prokaryotic expression systems, yeast expression systems, and other expression systems. On the basis of products, global recombinant expression systems market is segments include competent cells, expression vectors, instruments, reagents, expression vectors, instruments, reagents, and services. Academic research institutes, contract research organizations (CRO), pharmaceutical and biotechnology companies, and other end users Hospitals, diagnostic laboratories, research institutes, and others are the end-user segmentation of the recombinant expression systems market. The geographic segments included in this report are North America, Europe, Asia and Rest of the World.
Some of the major players of recombinant expression systems market include, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Life Technologies Corp., Merck Millipore, New England Biolabs, Inc., Promega Corp., QIAGEN, Sigma-Aldrich Corp., Takara Bio, Inc., and Thermo Fischer Scientific Inc.
Decision Databases is involved in providing research reports and company profiles in the global recombinant expression systems market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The recombinant expression systems market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our recombinant expression systems profiles.
1 Introduction
1.1 Overview
1.2 Objectives Of Study
1.3 Market Defination and Scope of the Study
1.3.1 Market Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points from Secondary Sources
1.5.4 Key Data Points from Primary Sources
1.6 Auxillary Factors
1.7 Assumptions
1.8 List of Acronyms
2 Executive Summary
3 Market Overview
3.1 Drivers
3.1.1 Increased Pharmaceutical Research
3.1.2 Growth in Biologics Market
3.1.3 Growth in Proteomics Market
3.2 Restraints
3.2.1 Decreased R&D Expenditure
3.2.2 High Market Consolidation
3.3 Opportunities
3.3.1 Developing Markets Hold Lucrative Potential
3.4 Supporting Data
3.4.1 Healthcare Expenditure
4 Global Recombinant Expression Systems Market, By Expression Systems
4.1 Insect Cell Expression Systems
4.2 Mammalian Cell Expression Systems
4.3 Prokaryotic Expression Systems
4.4 Yeast Expression Systems
4.4 Other Expression Systems
5 Global Recombinant Expression Systems Market, By Products
5.1 Competent Cells
5.2 Expression Vectors
5.3 Instruments
5.4 Reagents
5.5 Expression Vectors
5.6 Instruments
5.7 Reagents
5.8 Services
6 Global Recombinant Expression Systems Market, By End User
6.1 Academic Research Institutes
6.2 Contract Research Organizations (CRO)
6.3 Pharmaceutical and biotechnology companies
6.4 Other end users
7 Geographic Analysis
7.1 North America
7.2 Europe
7.3 Asia
7.4 Rest of the World (RoW)
8 Competitive Landscape
8.1 Global Recombinant Expression Systems Market, BY COMPANIES
8.2 Global Recombinant Expression Systems Market, BY DEVELOPMENTS
9 Company Profiles
9.1 Agilent Technologies, Inc
9.1.1 Overview
9.1.2 Product Portfolio
9.1.3 Financials
9.1.4 Strategic Approaches Through Business Expansion & Development
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Overview
9.2.2 Product Portfolio
9.2.3 Financials
9.2.4 Strategic Approaches Through Business Expansion & Development
9.3 Life Technologies Corporation
9.3.1 Overview
9.3.2 Product Portfolio
9.3.3 Financials
9.3.4 Strategic Approaches Through Business Expansion & Development
9.4 Merck Millipore
9.4.1 Overview
9.4.2 Product Portfolio
9.4.3 Financials
9.4.4 Strategic Approaches Through Business Expansion & Development
9.5 New England Biolabs, Inc.
9.5.1 Overview
9.5.2 Product Portfolio
9.5.3 Financials
9.5.4 Strategic Approaches Through Business Expansion & Development
9.6 Promega Corporation
9.6.1 Overview
9.6.2 Product Portfolio
9.6.3 Financials
9.6.4 Strategic Approaches Through Business Expansion & Development
9.7 Qiagen
9.7.1 Overview
9.7.2 Product Portfolio
9.7.3 Financials
9.7.4 Strategic Approaches Through Business Expansion & Development
9.8 Sigma-Aldrich Corporation
9.8.1 Overview
9.8.2 Product Portfolio
9.8.3 Financials
9.8.4 Strategic Approaches Through Business Expansion & Development
9.9 Takara Bio, Inc.
9.9.1 Overview
9.9.2 Product Portfolio
9.9.3 Financials
9.9.4 Strategic Approaches Through Business Expansion & Development
9.10 Thermo Fischer Scientific Inc.
9.10.1 Overview
9.10.2 Product Portfolio
9.10.3 Financials
9.10.4 Strategic Approaches Through Business Expansion & Development
The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
Global Risperidone Market Research Report 2017
The Global Risperidone Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
Global Caffeine Market Research Report 2017
The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, read more..
Global Rabies Vaccine Market Research Report 2017
The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
United States Parkinsons Disease Drug Market Report 2018-2025
The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers, read more..
Global Radiopharmaceuticals Market Research Report 2019
The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This read more..
Global Neurorehabilitation System Market Research Report
Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method read more..
Global Molecular Biology Kits And Reagents Market Research Report
The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in read more..
Global High Acuity Care Information Systems Market Research Report
The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus read more..
Global Regenerative Medicine Market Research Report
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..